An Exploratory Single-arm Study: PD-1 With Recombinant Human Adenovirus Type 5 Injection for Malignant Melanomas

Clinical trial NCT05928962 · UNKNOWN

Trial details

NCT number: NCT05928962
Sponsor: Fujian Cancer Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Melanomas

Start date: 2022-10-27
Primary completion: 2023-08-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.